Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 64.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 64.60
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 5,894,213
  • Market Cap: £349.21m
  • RiskGrade: 119
  • Beta: 0.01

Latest ShareCast News

Alliance Pharma confident despite softer sales

By Abigail Townsend

Date: Tuesday 08 Apr 2025

(Sharecast News) - Alliance Pharma posted weaker full-year revenues on Tuesday, but insisted it remained well-positioned for medium-term growth.

Alliance Pharma Regulatory News

Form 8.3 - ALLIANCE PHARMA PLC 08-May-2025 14:48 RNS
Form 8.3 - Alliance Pharma PLC 08.05.2025 08-May-2025 12:53 RNS
Form 8.3 - Alliance Pharma Plc 08-May-2025 12:02 RNS
Form 8.5 (EPT/RI) - Alliance Pharma plc 08-May-2025 10:14 RNS
Form 8.3 - ALAPH LN 07-May-2025 15:30 RNS

Alliance Pharma News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 64.60
52 Week Low 29.35
Volume 5,894,213
Shares Issued 540.57m
Market Cap £349.21m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.24% above the market average24.24% above the market average24.24% above the market average24.24% above the market average24.24% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Price Trend
74.42% above the market average74.42% above the market average74.42% above the market average74.42% above the market average74.42% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Income Not Available
Growth
49.61% below the market average49.61% below the market average49.61% below the market average49.61% below the market average49.61% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 08-May-2025

Time Volume / Share Price
16:35 222,736 @ 64.60p
16:35 924 @ 64.60p
16:35 810 @ 64.60p
16:35 1,700 @ 64.60p
16:35 1,734 @ 64.60p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page